AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 13, 2026

TeraStor Introduces Kinetra Digital Twin and Simulation Platform for AI Data Centers
New November 2026 Data: Back Bay Homes Sell for 97.5% of Asking Price
The Cordeiro Group Announces Executive Promotions to Support Company’s Strategic Growth
Liberty Defense Clarifies Previously Announced Credit Facility and Term Loan
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
T1 Energy (TE) Falls Over 18% After Disclosing SEC Probe; Contact Block & Leviton to Discuss Recovery Options
CADL INVESTIGATION: Candel Therapeutics Investigated for Securities Fraud by Block & Leviton: Investors Should Contact the Firm
Susan R. Burns, Ph.D., to Receive the 2027 Courageous Leadership Award
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
Global 3D Printing Drugs Market to Reach $540.4 Million by 2031
Stop & Shop Launches Thanksgiving Feast for Eight for Under $40 This Thanksgiving
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026
Fortress Biotech Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Zevra Therapeutics Announces Final CHMP Opinion on Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
Molecular Partners to Present at Inaugural UBS Global Biopharma Conference
Liberty Defense Announces Investor Relations Engagement with Global Impact Advisors LLC

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.